A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Clinical trial NCT07259564 · TERMINATED
Trial details
- NCT number
- NCT07259564
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2026-04-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.